3rd Circ. Pay-For-Delay Ruling Opens Door To High Court

By Melissa Lipman (July 16, 2012, 7:50 PM EDT) -- The Third Circuit ruled Monday that payments from pharmaceutical makers to generics companies to settle patent litigation are evidence that a deal might violate federal antitrust law, rejecting the more lenient standard applied by other circuits and creating an opening for the long-simmering pay-for-delay debate to reach the U.S. Supreme Court....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!